Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →Jimmy Carter was diagnosed with metastatic melanoma in 2015, after a tumor was removed from his liver. The cancer had also spread to four small sites in his brain. His reported care combined surgery, focused radiation to the brain lesions and pembrolizumab immunotherapy. In December 2015, Carter said an MRI showed none of the original brain spots and no new ones. He died in December 2024, making “nine years” a rounded span from diagnosis to death—not nine documented years of continuously active cancer.
What cancer did Jimmy Carter have?
In August 2015, Carter announced that he had melanoma in his liver and that further scans had identified four places in his brain. Emory University reported that surgeon Juan M. Sarmiento had removed a tumor from Carter’s liver earlier that month. The findings meant the melanoma had spread beyond its original site.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
His Very Best: Jimmy Carter, a Life | $11.32 | Buy on Amazon |
| 2 |
|
A Full Life: Reflections at Ninety | $9.89 | Buy on Amazon |
| 3 |
|
Jimmy Carter: A Little Golden Book Biography | $5.32 | Buy on Amazon |
| 4 |
|
The Virtues of Aging (Library of Contemporary Thought) | $7.74 | Buy on Amazon |
| 5 |
|
An Hour Before Daylight: Memories of a Rural Boyhood | $9.32 | Buy on Amazon |
Emory’s Aug. 21, 2015 account describes the diagnosis and treatment details. The Carter Center’s later health statement does not provide a full account of Carter’s cancer status in his final years, so the public timeline should not be read as a record of ongoing, visible cancer throughout the entire period.
What treatment did Carter receive?
His publicly reported treatment addressed the disease in different ways: surgery removed the liver mass, stereotactic radiation targeted the brain lesions, and pembrolizumab was given as systemic immunotherapy. Emory reported that Carter received one stereotactic radiation treatment on Aug. 20, 2015, and four pembrolizumab infusions at three-week intervals.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →#1 Best Overall
Pembrolizumab, also known by the brand name Keytruda, is an immune checkpoint inhibitor. It blocks the PD-1 receptor, helping release a restraint on immune cells so they can attack cancer. Radiation damages cancer cells in the targeted area. These treatments had complementary roles, but the available public accounts do not establish that any one of them would have been sufficient on its own.
The American Association for Cancer Research reproduced Carter’s Dec. 6, 2015 update: “My most recent MRI brain scan did not reveal any signs of the original cancer spots nor any new ones.” He said he would continue regular pembrolizumab treatment every three weeks. That MRI report was an important early sign of response, but it was not a statement that treatment had ended.
Rank #2
Can one treatment be credited with his remission?
No. Carter’s case shows that he received surgery, radiation and immunotherapy, followed by a report of no visible original or new brain lesions on a scan. It does not prove that pembrolizumab alone—or any single intervention—caused the result. Dana-Farber Cancer Institute melanoma specialist Elizabeth Buchbinder described radiation and pembrolizumab as working in different ways; the institute also cautioned that doctors could not be certain the treatment caused Carter’s remission.
Dana-Farber’s discussion explains the treatments’ mechanisms and the limits of what could be concluded from one patient’s outcome. Carter’s survival was remarkable, but his experience cannot predict another person’s response or guarantee that the same regimen will work for them.
Recommended Free Tools
Rank #3
Why is “nine years” an approximate timeline?
Carter disclosed his diagnosis in August 2015 and died in December 2024, roughly nine years and four months later. The phrase “survived cancer for nine years” is therefore a rounded interval between diagnosis and death; it should not be taken to mean he had active melanoma for all nine years.
In February 2023, The Carter Center said he had chosen home hospice after a series of short hospital stays and had decided not to pursue additional medical intervention. That statement did not identify melanoma as the reason for hospice. It is not evidence that the cancer had returned or that it prompted the decision. The Carter Center’s statement describes the choice without attributing it to a particular diagnosis.
Quick Recap
Best Value
- Author: jimmy-carter.
- Publisher: Fisicalbook
- Pages: 288
- Publication Date: 2002
- Edition: Illustrated
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
